MNSO (09896) spent approximately US$238,600 to repurchase 108,800 shares on September 25.
MINISO (09896) announced that on September 25, 2026, it spent approximately US$238,600 to repurchase 108,800 shares.
MNSO (09896) announced that on September 25, 2026, it spent approximately US$238,600 to repurchase 108,800 shares.
Related Articles
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list
FANGZHOU JIANKE (06086) Caina Technology Incentive Plan
Sichuan Biokin Pharmaceutical (688506.SH): Clinical trial of BL-M12D1 for injection (ADC) approved
Sichuan Biokin Pharmaceutical (688506.SH): Yizekang included in the breakthrough therapy designation list
FANGZHOU JIANKE (06086) Caina Technology Incentive Plan
